| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.6 |